Health TrialsbyHealthPanel

Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment

ConditionsOpioid UseOpioid Abuse
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmory University

About this trial

The overarching goal of this project is to increase the availability of OUD treatment in rural counties in the state of Georgia by using Emergency Department (ED)-based telehealth strategies to initiate MOUD and connect patients to treatment.

The investigators will implement a novel collaboration between rural EDs, medical toxicologists at the Georgia Poison Center (GPC), peer recovery coaches (PRCs) and RCOs throughout Georgia to bridge the gap between OUD treatment need in rural EDs and specialty physician availability at the GPC.

Research activities will be conducted during two broad phases, at three rural EDs in Georgia: planning and implementation. During the planning phase, aggregate data will be obtained to determine each ED's existing practices treating patients with OUD and opioid withdrawal. During the implementation phase, the researchers will prospectively study a poison center OUD consultation and PRC intervention as it is rolled out at each site, collecting participant-level data. Sites will be rolled into the implementation phase in a stepped-wedge fashion, so there will be times when some sites are in the planning phase while others are in the implementation phase.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 years or older

English speaking

Clinically sober

Medically and psychiatrically stable

Disqualifiers

Already receiving MAT or psychotherapy for OUD prior to ED arrival

Prior participation in the study

Unable to provide informed consent

If their clinical condition worsens such that continued participation would be considered unsafe in the opinion of the PRC or ED staff

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sociobehavioral Intervention

    Behavioral

    Utilizes two primary evidence-based strategies: * Delivering OUD consultation via telemedicine, which has been demonstrated to be a safe and effective means for initiating MOUD with buprenorphine; and, * Incorporating psychosocial support in the form of PRC, whose involvement in patient care is associated with increased treatment retention and MOUD initiation.

Treatment groups

480 Participants
are divided into 2 treatment groups
Group A: Sociobehavioral program GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in number of patients who present with acute opioid withdrawal, acute opioid overdose, or requesting treatment for OUD (Opioid Use Disorder)

Change in number of patients who present with acute opioid withdrawal, acute opioid overdose, or requesting treatment for OUD will be collected

Time frame
Baseline, 3 months post intervention, and 1 year post intervention
2

Change in number of patients evaluated for MOUD (Medication for Opioid Use Disorder)

Change in number of patients evaluated for MOUD will be collected

Time frame
Baseline, 3 months post intervention, and 1 year post intervention
3

Change in number of patients started on MOUD

Change in number of patients started on MOUD will be collected

Time frame
Baseline, 3 months post intervention, and 1 year post intervention
4

Change in number of patients discharged with a prescription for MOUD

Change in number of patients discharged with a prescription for MOUD will be collected

Time frame
Baseline, 3 months post intervention, and 1 year post intervention

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Emory University

Lead sponsor

Source ClinicalTrials.gov
Apply now